These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24852924)

  • 61. Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
    Alsaadi T; El Hammasi K; Shahrour TM; Shakra M; Turkawi L; Mudhafar A; Diab L; Raoof M
    Mult Scler Int; 2015; 2015():487159. PubMed ID: 26240760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
    Esiri M
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):396. PubMed ID: 10787314
    [No Abstract]   [Full Text] [Related]  

  • 63. The link between multiple sclerosis and depression.
    Feinstein A; Magalhaes S; Richard JF; Audet B; Moore C
    Nat Rev Neurol; 2014 Sep; 10(9):507-17. PubMed ID: 25112509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.
    Marrie RA; Reingold S; Cohen J; Stuve O; Trojano M; Sorensen PS; Cutter G; Reider N
    Mult Scler; 2015 Mar; 21(3):305-17. PubMed ID: 25583845
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
    Salari S; Khomand P; Arasteh M; Yousefzamani B; Hassanzadeh K
    Pharmacol Rep; 2015 Jun; 67(3):606-9. PubMed ID: 25933976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is personality profile a relevant determinant of fatigue in multiple sclerosis?
    Schreiber H; Lang M; Kiltz K; Lang C
    Front Neurol; 2015; 6():2. PubMed ID: 25699007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.
    Marrie RA; Cohen J; Stuve O; Trojano M; Sørensen PS; Reingold S; Cutter G; Reider N
    Mult Scler; 2015 Mar; 21(3):263-81. PubMed ID: 25623244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Sorensen PS; Cutter G; Reingold SC; Trojano M
    Mult Scler; 2015 Mar; 21(3):282-93. PubMed ID: 25533299
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.
    Solaro C; Gamberini G; Masuccio FG
    CNS Drugs; 2018 Feb; 32(2):117-133. PubMed ID: 29417493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis.
    Boeschoten RE; Braamse AMJ; Beekman ATF; Cuijpers P; van Oppen P; Dekker J; Uitdehaag BMJ
    J Neurol Sci; 2017 Jan; 372():331-341. PubMed ID: 28017241
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Depression in multiple sclerosis.
    Patten SB; Marrie RA; Carta MG
    Int Rev Psychiatry; 2017 Oct; 29(5):463-472. PubMed ID: 28681616
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiple sclerosis and suicide.
    Feinstein A; Pavisian B
    Mult Scler; 2017 Jun; 23(7):923-927. PubMed ID: 28327056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Depression and anxiety in multiple sclerosis. Review of a fatal combination.
    Jellinger KA
    J Neural Transm (Vienna); 2024 Aug; 131(8):847-869. PubMed ID: 38869643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review.
    Fernández Ó; Sörensen PS; Comi G; Vermersch P; Hartung HP; Leocani L; Berger T; Van Wijmeersch B; Oreja-Guevara C
    Front Immunol; 2024; 15():1379538. PubMed ID: 38646534
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In-Hospital Symptoms of Depression and Anxiety are Strong Risk Factors for Post-Stroke Depression 90 Days After Ischemic Stroke.
    Elias S; Benevides ML; Pereira Martins AL; Martins GL; Sperb Wanderley Marcos AB; Nunes JC
    Neurohospitalist; 2023 Apr; 13(2):121-129. PubMed ID: 37064927
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Subtypes of relapsing-remitting multiple sclerosis identified by network analysis.
    Howlett-Prieto Q; Oommen C; Carrithers MD; Wunsch DC; Hier DB
    Front Digit Health; 2022; 4():1063264. PubMed ID: 36714613
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis - a randomized trial.
    Smyth P; Watson KE; Al Hamarneh YN; Tsuyuki RT
    BMC Neurol; 2022 Jul; 22(1):275. PubMed ID: 35879701
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial.
    Smyth P; Watson KE; Tsuyuki RT
    Trials; 2021 Nov; 22(1):785. PubMed ID: 34749784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical Practice.
    Haines S; Butler E; Stuckey S; Hester R; Grech LB
    Int J MS Care; 2021; 23(4):178-185. PubMed ID: 34483757
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pilot study of the impact of an exercise intervention on brain structure, cognition, and psychosocial symptoms in individuals with relapsing-remitting multiple sclerosis.
    Mayo CD; Harrison L; Attwell-Pope K; Stuart-Hill L; Gawryluk JR
    Pilot Feasibility Stud; 2021 Mar; 7(1):65. PubMed ID: 33685527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.